Affiliations: INSERM U. 577, Université Victor Segalen Bordeaux 2, 146, rue Léo Saignat, 33076 Bordeaux cedex, France | Service de Chirurgie Vasculaire, Centre Hospitalier Universitaire, Pellegrin Tripode, 146, rue Léo Saignat, 33076 Bordeaux cedex, France
Note: [] Corresponding author: Pr. Laurence Bordenave, INSERM U. 577, Université Victor Segalen Bordeaux 2, 146, rue Léo-Saignat, 33076 Bordeaux cedex, France. Tel.: +33 05 57 57 14 83; Fax: +33 05 56 90 05 17; E-mail: Laurence.Bordenave@ u-bordeaux2.fr.
Abstract: The replacement of arteries with synthetic vascular prostheses often leads to failure when small-diameter or low-flow locations are concerned, due in part to the thrombogenicity of the graft surface. In order to improve long-term patency of these grafts, the concept of endothelial cell seeding has been suggested, the composite structure resulting from the combination of biologically active cells to prosthetic materials thus creating more biocompatible vascular substitutes. To achieve endothelialization of synthetic grafts, previous efforts aimed at “one-stage” procedure in the 1980's seemed clinically feasible but results of reported clinical trials were controversial and mostly disappointing. An alternative method is an in vitro complete and preformed endothelial lining at the time of implantation: the “two-stage” procedure which implies harvest and culture of autologous endothelial cells. Up to date, the latter approach demonstrated its superiority in terms of significantly increased patency of the grafts that underwent endothelialization several years earlier.
